Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Methotrexate and TNF inhibitors affect long-term immunogenicity to COVID-19 vaccination in patients with immune-mediated inflammatory disease.
Haberman RH, Um S, Axelrad JE, Blank RB, Uddin Z, Catron S, Neimann AL, Mulligan MJ, Herat RS, Hong SJ, Chang S, Myrtaj A, Ghiasian G, Izmirly PM, Saxena A, Solomon G, Azar N, Samuels J, Golden BD, Rackoff P, Adhikari S, Hudesman DP, Scher JU; SAGA investigators. Haberman RH, et al. Among authors: catron s. Lancet Rheumatol. 2022 Jun;4(6):e384-e387. doi: 10.1016/S2665-9913(22)00069-8. Epub 2022 Apr 1. Lancet Rheumatol. 2022. PMID: 35403000 Free PMC article. No abstract available.
Low incidence and transient elevation of autoantibodies post mRNA COVID-19 vaccination in inflammatory arthritis.
Blank RB, Haberman RH, Qian K, Samanovic M, Castillo R, Jimenez Hernandez A, Vasudevapillai Girija P, Catron S, Uddin Z, Rackoff P, Solomon G, Azar N, Rosenthal P, Izmirly P, Samuels J, Golden B, Reddy S, Mulligan MJ, Hu J, Scher JU. Blank RB, et al. Among authors: catron s. Rheumatology (Oxford). 2022 Dec 23;62(1):467-472. doi: 10.1093/rheumatology/keac322. Rheumatology (Oxford). 2022. PMID: 35640110 Free PMC article.
Efficacy of guselkumab, a selective IL-23 inhibitor, in Preventing Arthritis in a Multicentre Psoriasis At-Risk cohort (PAMPA): protocol of a randomised, double-blind, placebo controlled multicentre trial.
Haberman RH, MacFarlane KA, Catron S, Samuels J, Blank RB, Toprover M, Uddin Z, Hu J, Castillo R, Gong C, Qian K, Piguet V, Tausk F, Yeung J, Neimann AL, Gulliver W, Thiele RG, Merola JF, Ogdie A, Rahman P, Chakravarty SD, Eder L, Ritchlin CT, Scher JU. Haberman RH, et al. Among authors: catron s. BMJ Open. 2022 Dec 23;12(12):e063650. doi: 10.1136/bmjopen-2022-063650. BMJ Open. 2022. PMID: 36564123 Free PMC article.
Racial and ethnic determinants of psoriatic arthritis phenotypes and disease activity.
Haberman RH, Ahmed T, Um S, Zhou YY, Catron S, Jano K, Felipe A, Eichman S, Rice AL, Lydon E, Moussavi S, Neimann AL, Reddy SM, Adhikari S, Scher JU. Haberman RH, et al. Among authors: catron s. Rheumatology (Oxford). 2024 Feb 1:keae066. doi: 10.1093/rheumatology/keae066. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38305279
Clinical Validation of Digitally Acquired Clinical Data and Machine Learning Models for Remote Measurement of Psoriasis and Psoriatic Arthritis: A Proof-of-Concept Study.
Webster DE, Haberman RH, Perez-Chada LM, Tummalacherla M, Tediarjo A, Yadav V, Neto EC, MacDuffie W, DePhillips M, Sieg E, Catron S, Grant C, Francis W, Nguyen M, Yussuff M, Castillo RL, Yan D, Neimann AL, Reddy SM, Ogdie A, Kolivras A, Kellen MR, Mangravite LM, Sieberts SK, Omberg L, Merola JF, Scher JU. Webster DE, et al. Among authors: catron s. J Rheumatol. 2024 Aug 1;51(8):781-789. doi: 10.3899/jrheum.2024-0074. J Rheumatol. 2024. PMID: 38879192